Register to chat with like-minded investors on our interactive forums.

Get Started

ABUS Arbutus Biopharma Corporation

4.14

0.01 (0.24%)

After Hours

Last Updated: 16:44:58

Delayed by 15 minutes

Arbutus receives regulatory approval to start early-stage HBV trial

To read the full story on Seeking Alpha, click here.

Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Arbutus Biopharma Charts.

Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Arbutus Biopharma Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Arbutus Biopharma Corporation News

More Arbutus Biopharma Corporation News Articles

Sincerity Applied Materi... (PK)

Brookmount Explorations (PK)

TransCode Therapeutics

Net Savings Link (PK)

Premier Biomedical (PK)

Clean Vision (QB)

Revance Therapeutics

NFT MarketPlace (PK)

Delayed Upgrade Clock